ORGANIZATION
Scientists
Dr. Ennio Tasciotti
PhD
Prof. Tasciotti is a pioneer in the development of biomimetic nanotechnologies for biomedical applications in the field of drug delivery with a solid expertise in coordinating highly interdisciplinary collaborative research groups in the context of large multi-center scientific programs with leading institutions (Harvard, MIT, Stanford, Northwestern, MD Anderson Cancer Center, Italian Ministry of Health, etc).
To be updated
Affiliation: IRCCS San Raffaele (Italy)
E-mail: ennio.tasciotti@sanraffaele.it
Dr. Marina Lusic
PhD
Dr Marina Lusic, PhD is a genome biologist with a long experience in studying epigenetic and genomic changes related to viral infections and identifying potentially druggable molecular pathways that restrict viral infections. Her team has proposed new drug targets for treatment of HIV-1 and most recently for SARS-CoV2 infection.
To be updated
Affiliation: Heidelberg University Hospital (Germany)
E-mail: Marina.lusic@med.uni-heidelberg.de
Dr. Luda Diatchenko
MD, PhD
Prof. Diatchenko has made seminal contributions to the field of human pain genetics identifying the pathophysiology of chronic pain, genetic markers for accurate diagnosis, and potential therapeutic targets. She pioneered a reverse genetic approach in pain using human samples rather than animal models as a starting point for discoveries.
To be updated
Affiliation: McGill University (Canada)
E-mail: luda.diatchenko@mcgill.ca
Dr. Assaf Zinger
PhD
Dr. Assaf Zinger is a Biomedical Engineer with vast experience in developing nanodelivery systems combining biomedical and chemical engineering with pharmacology. He holds two academic affiliations both at Technion-Israel Institute of Technology and Houston Methodist Academic Institute, TX, USA.
To be updated
Affiliation: Technion – Israel Inst. of Technology (Israel)
E-mail: assafzinger@technion.ac.il
Dr. Carolina Muscoli
PhD
Prof. Muscoli has a long experience in understanding the molecular mechanisms at the basis of chronic pain and in developing innovative pharmaceutical and nutraceutical treatments for acute and chronic pain from the animal models to human trials.
To be updated
Affiliation: Università Magna Graecia (Italy)
E-mail: muscoli@unicz.it
Clinicians
Prof. Pablo Ingelmo
Dr. Ingelmo is a paediatric pain specialist with an extensive experience in pain children and adolescents. He has also advocated to the description of psychosocial and biological phenotypes of children with chronic primary pain.
To be updated
Affiliation: Montreal Childrens Hospital (Canada)
E-mail: pablo.ingelmo@mcgill.ca
Prof. Sam Eldabe
MD
Prof. Eldabe is one of the most important researchers in the development of new treatments for chronic pain, especially in neuromodulation, collaborating in several clinical studies. He is currently involved in a European study about long COVID and pain
To be updated
Affiliation: The James Cook University Hospital, Hospitals NHS Foundation Trust (UK)
E-mail: seldabe@nhs.net
Prof. Gisele Pickering
MD, PhD
Prof. Gisele Pickering basic research concerns the mechanisms of action of analgesics, including NMDA antagonists for severe chronic pain, while her clinical research includes over 30 trials/year on pain research.
To be updated
Affiliation: University Hospital of Clermont-Ferrand (France)
E-mail: gisele.pickering@uca.fr
Dr. Assaf Zinger
MD
Prof. Volk is chair and head of the university pain clinic. He is the president of the European Society on Regional Anesthesia and Pain Medicine.
To be updated
Affiliation: Saarland University (Germany)
E-mail: Thomas.volk@uks.eu
Prof. Dragan Primorac
MD, PhD
Prof. Dragan Primorac is a pediatrician and a medical geneticist who pioneered the understanding of the genetics of pain and the integration of the personalized medicine in clinical practice. His interest is in the use of pharmacogenomics for treatment optimization and pain management. He recently initiated one of the largest EU projects on low-back pain to understand the OMICS bases of low-back pain.
To be updated
Affiliation: St. Catherine Hospital (Croatia)
Email: office@draganprimorac.com
Dr. César Fernández-de-las-Peñas
MD
Dr. Fernandez de las Peñas is the PI of the LONG COVID EXPERIENCE Study, a European study focused on clinical, neurophysiological and epigenetics mechanisms of long-COVID, and an active researcher on the pan-European long COVID pain study. Dr. Fernández provided clinical definitions of long-COVID, and contributed to the post-COVID literature with more than 70 peer-reviewed publications.
To be updated
Affiliation: Universidad Rey Juan Carlos (Spain)
E-mail: cesar.fernandez@urjc.es
Prof. Jean-Pierre Van Buyten
MD
Dr. Jean-Pierre Van Buyten MD, PhD. is currently the Chairman of The Multidisciplinary Pain Management Center in AZ Nikolaas Hospital in Sint-Niklaas Belgium and Consultant in Pain Medicine in Delta Hospital Brussels Belgium.
To be updated
Affiliation: Multidisciplinary Pain Center. Vitaz hospital. Sint – Niklaas (Belgium)
E-mail: info@drvanbuyten.be
Prof. Lars Arendt-Nielsen
MD
Prof Arendt-Nielsen, ex past president of International Association of Pain he is one of the most contributors in studies about the evaluating of central sensitization and how acute pain can become chronic.
To be updated
Affiliation: Aalborg University and Aalborg University Hospital (Denmark)
E-mail: lan@hst.aa.dk
Dr. Massimo Allegri
MD, PhD
Dr. Massimo Allegri is a clinician with clinical and research experience in chronic pain with a special focus on translational medicine and the clinical use of genomics to better understand acute and chronic pain. He serves as Pi of a European Study on genomics and pain and he is an active researcher on the pan-European long COVID pain study.
To be updated
Affiliation: Ensemble Hospitalier de la Cote – Centre Lemanique d’antalgie et neuromodulation (Switzerland)
E-Mail: massimo.allegri@ehc.vd.ch
Companies
Dr. Gordan Lauc
MD
Dr Lauc with his company is providing new important diagnostic and pathophysiologic insights in chronic inflammatory diseases through the glycomics studies. He has already performed some studies about glycomics as a possible biomarker in Covid, and also marker of pain.
To be updated
Affiliation: Genos Ltd (Canada)
E-mail: glauc@genos.hr
Dr. Filippo Sertorio
Dr. Sertorio has been the president of Procemsa, one of the leading CDMO in Europe with experience in phytopharma, food supplements, and therapeutics formulations with several patents in the field of natural products, delivery platforms, and production processes. Dr. Sertorio is an expert in developing strategic projects and transforming ideas into concrete translational projects.
To be updated
Affiliation: Bluejays srl (Italy)
E-mail: filippo.sertorio@gmail.com
Dr. Nicoletta Marchesi
PhD
Reudyneuheart is a biotech start-up focused on new molecules and new drug targets for known molecules. Dr Marchesi interest is in neurodegenerative diseases and on the biology of ELAV proteins. She discovered new mechanism-based targets for integrators for nociplastic pain.
To be updated
Affiliation: REDYNEUHEART SRL (Italy)
E-mail: nicbiology86@gmail.com
Associations
Dr. Andrea Fanelli
MD
The Association REDIRECT PAIN aims to promote and share education and training programs in the field of acute and chronic perioperative pain management.
To be updated
Affiliation: Redirect Pain (Italy)
E-mail: info@redirectpain.it